No votes yet
Letters to the Editor

Letters to the Editor

Deborah K. Mayer
CJON 2014, 18(2), 143-145 DOI: 10.1188/14.CJON.143-145

Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to CJONEditor@ons.org.


Zhao, Y., Ding, Y., Lu, Y., Zhang, J., Gu, J., & Li, M. (2013). Incidence and self-management of hand-foot syndrome in patients with colorectal cancer. <i>Clinical Journal of Oncology Nursing, 17</i>, 434-437. doi:10.1188/13.CJON.434-437

Blake, M. (2010). Dirty medicine. <i>Washington Monthly.</i> Retrieved from http://www.washingtonmonthly.com/features/2010/1007.blake.html <a target="_blank" href='http://www.washingtonmonthly.com/features/2010/1007.blake.html'>http://w...

Blumenthal, R. (2006). <i>Testimony of Attorney General Richard Blumenthal before the Antitrust, Competition Policy, and Consumer Rights Subcommittee of the Senate Judiciary Committee.</i> Retrieved from <a target="_blank" href='http://www.puncturemovie.com/wp-content/themes/Romix/pdfs/ctag-senate-te...

Bogdanich, W. (2002, March 4). Two powerful groups hold sway over buying at many hospitals. <i>New York Times.</i> Retrieved from http://www.nytimes.com <a target="_blank" href='http://www.nytimes.com'>http://www.nytimes.com</a>

Cherici, C., Frazier, J. Feldman, M., Gordon, B., Petrykiw, C. A., Russell, W. L., & Souza, J. (2011). <i>Navigating drug shortages in American healthcare: A Premier healthcare alliance analysis.</i> Retrieved from <a target="_blank" href='http://www.premierinc.com/about/news/11-mar/drug-shortage-white-paper-3-...

Cherici, C., McGinnis, P., & Russell, W. (2011). <i>Buyer beware: Drug shortages and the gray market.</i> Retrieved from <a target="_blank" href='http://www.premierinc.com/about/news/11-aug/Gray-Market/Gray-Market-Anal...

Clapp, M., Rie, M. A., & Zweig, P. L. (2013, September 3). How a cabal keeps generics scarce. <i>New York Times</i>, p. A25.

Earl, P., & Zweig, P. L. (2012). <i>Connecting the dots: How anticompetitive contracting practices, kickbacks, and self-dealing by hospital group purchasing organizations (GPOs) caused the U. S. drug shortage.</i> Retrieved from <a target="_blank" href='http://www.puncturemovie.com/wp-content/themes/Romix/pdfs/earlzweigfinal...

Healthcare Purchasing News. (2012). GPO facts and figures: Largest group purchasing organizations. Retrieved from <a target="_blank" href='http://www.hpnonline.com/resources/GPOs.html'>http://www.hpnonline.com/r...

<i>Hospital group purchasing: Are the industry's reforms sufficient to ensure competition? Hearing before the Subcommittee on Antitrust, Competition Policy, and Consumer Rights, Senate</i>, 109th Cong. 2 (2006).

<i>Hospital group purchasing: Has the market become more open to competition? Hearing before the Subcommittee on Antitrust, Business Rights, and Competition of the Committee of the Judiciary, Senate</i>, 108th Cong. 1 (2003).

<i>Hospital group purchasing: How to maintain innovation and cost savings: Subcommittee on Antitrust, Competition Policy, and Consumer Rights, Senate</i>, 108th Cong. 2 (2004).

<i>Hospital group purchasing: Lowering costs at the expense of patient health and medical innovations?: Subcommittee on Antitrust, Business Rights, and Competition, Senate</i>, 107th Cong. 2 (2002).

Lambert, E. (2007, March 9). Battle scarred. <i>Forbes.</i> Retrieved from http://www.forbes.com/forbes/2007/0326/092.html <a target="_blank" href='http://www.forbes.com/forbes/2007/0326/092.html'>http://www.forbes.com/f...

Litan, R. E., Singer, H. J., & Birkenbach, A. (2011). An empirical analysis of aftermarket transactions by hospitals. <i>Journal of Contemporary Health Law and Policy, 28</i>, 23-38.

McKeever, A. E., Rosen Bloch, J., & Bratic, A. (2013). Drug shortages and the burden of access to care: A critical issue affecting patients with cancer. <i>Clinical Journal of Oncology Nursing, 17</i>, 490-495. doi:10.1188/13.CJON.490-495

Moss, D. L. (2012). <i>Healthcare intermediaries: Competition and healthcare policy at loggerheads?</i> Retrieved from <a target="_blank" href='http://bit.ly/1hXZJVM'>http://bit.ly/1hXZJVM</a>

Porter, M. E., & Teisberg, E. O. (2006). <i>Redefining healthcare: Creating value-based competition on results.</i> Boston, MA: Harvard Business Review Press.

Sethi, S. P. (2009). <i>Group purchasing organizations: An undisclosed scandal in the U. S. healthcare industry.</i> New York, NY: Palgrave Macmillan.

Smith, H. (2003). Retractable v. Becton, Dickinson et al. <i>American Lawyer.</i> Retrieved from http://bit.ly/1cnrKIl <a target="_blank" href='http://bit.ly/1cnrKIl'>http://bit.ly/1cnrKIl</a>

U. S. Food and Drug Administration. (2013). <i>Strategic plan for preventing and mitigating drug shortages.</i> Retrieved from <a target="_blank" href='http://1.usa.gov/1mQ1QS0'>http://1.usa.gov/1mQ1QS0</a>

U. S. Government Accountability Office. (2002). <i>Group purchasing organizations: Pilot study suggests large buying groups do not always offer hospitals lower prices.</i> Retrieved from <a target="_blank" href='http://www.gao.gov/assets/90/81813.pdf'>http://www.gao.gov/assets/90/818...

U. S. Government Accountability Office. (2012). <i>Group purchasing organizations: Federal oversight and self-regulation.</i> Retrieved from <a target="_blank" href='http://www.gao.gov/assets/590/589778.pdf'>http://www.gao.gov/assets/590/...

U. S. Government Accountability Office. (2014). <i>Drug shortages: Public health threat continues, despite efforts to help ensure product availability.</i> Retrieved from <a target="_blank" href='http://www.gao.gov/assets/670/660785.pdf'>http://www.gao.gov/assets/670/...

Walsh, M. W. (2002, March 26). When a buyer for hospitals has a stake in drugs it buys. <i>New York Times.</i> Retrieved from http://www.nytimes.com <a target="_blank" href='http://www.nytimes.com'>http://www.nytimes.com</a>

Wilkerson, J. (2011). HHS rejected ASP hike after weighing GPO, drug distribution issues. <i>InsideHealthPolicy.com.</i> Retrieved from http://www.insidehealthpolicy.com <a target="_blank" href='http://www.insidehealthpolicy.com'>http://www.insidehealthpolicy.com</a>

Woodcock, J., & Wosinska, M. (2013). Economic and technological drivers of generic sterile injectable drug shortages. <i>Clinical Pharmacology and Therapeutics, 93</i>, 170-176.

Wosinska, M. (2013, November 11). Solving drug shortages requires incentivizing reliability, infrastructure quality. <i>Bloomberg Brief.</i> Retrieved from http://bit.ly/OSSC8F <a target="_blank" href='http://bit.ly/OSSC8F'>http://bit.ly/OSSC8F</a>

Zweig, P. L., & Zellner, W. (1998, March 16). Locked out of the hospital. <i>Business Week.</i> Retrieved from http://www.businessweek.com/stories/1998-03-15/locked-out-of-the-hospital <a target="_blank" href='http://www.businessweek.com/stories/1998-03-15/locked-out-of-the-hospita...